Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025
Revolution Medicines (Nasdaq: RVMD) will report third-quarter 2025 financial results on Wednesday, November 5, 2025 after market close.
The company said a senior management webcast will begin at 4:30 p.m. ET / 1:30 p.m. PT to discuss results and provide a corporate update. Investors can listen live or access the archived webcast at https://ir.revmed.com/events-and-presentations. A replay will be available on the company website for at least 14 days following the live event.
Revolution Medicines (Nasdaq: RVMD) riferirà i risultati finanziari del terzo trimestre 2025 il mercoledì 5 novembre 2025 dopo la chiusura del mercato.
L'azienda ha detto che una webcast della direzione senior inizierà alle 16:30 ET / 13:30 PT per discutere i risultati e fornire un aggiornamento aziendale. Gli investitori possono ascoltare in diretta o accedere al webcast registrato su https://ir.revmed.com/events-and-presentations. Una replica sarà disponibile sul sito web dell'azienda per almeno 14 giorni successivi all'evento in diretta.
Revolution Medicines (Nasdaq: RVMD) presentará los resultados financieros del tercer trimestre de 2025 el miércoles 5 de noviembre de 2025 después del cierre del mercado.
La empresa dijo que una webcast de la alta dirección comenzará a las 16:30 ET / 13:30 PT para discutir los resultados y brindar una actualización corporativa. Los inversionistas pueden escuchar en vivo o acceder al webcast archivado en https://ir.revmed.com/events-and-presentations. Una reproducción estará disponible en el sitio web de la empresa durante al menos 14 días después del evento en vivo.
Revolution Medicines (나스닥: RVMD)는 2025년 3분기 재무 결과를 2025년 11월 5일 수요일 장 마감 후에 발표합니다.
회사는 고위 경영진의 웹캐스트가 동부 표준시 16:30 / 태평양 표준시 13:30에 시작되어 결과를 논의하고 기업 업데이트를 제공할 것이라고 밝혔습니다. 투자자들은 실시간으로 청취하거나 https://ir.revmed.com/events-and-presentations의 보관된 웹캐스트에 접속할 수 있습니다. 라이브 이벤트 이후 최소 14일 동안 회사 웹사이트에서 재방송이 제공됩니다.
Revolution Medicines (Nasdaq : RVMD) publiera les résultats financiers du troisième trimestre 2025 le mercredi 5 novembre 2025 après la clôture des marchés.
La société a indiqué qu'un webcast de la direction générale débutera à 16h30 ET / 13h30 PT pour discuter des résultats et fournir une mise à jour de l'entreprise. Les investisseurs peuvent écouter en direct ou accéder au webcast archivé sur https://ir.revmed.com/events-and-presentations. Une rediffusion sera disponible sur le site de l'entreprise pendant au moins 14 jours après l'événement en direct.
Revolution Medicines (Nasdaq: RVMD) wird die Finanzergebnisse des dritten Quartals 2025 am Mittwoch, dem 5. November 2025 nach Börsenschluss berichten.
Das Unternehmen gab bekannt, dass eine Webcast-Präsentation des Senior-Managements um 16:30 Uhr ET / 13:30 Uhr PT beginnen wird, um Ergebnisse zu besprechen und ein Unternehmens-Update bereitzustellen. Investoren können live zuhören oder den archivierten Webcast unter https://ir.revmed.com/events-and-presentations abrufen. Eine Wiederholung wird für mindestens 14 Tage nach der Live-Veranstaltung auf der Unternehmenswebsite verfügbar sein.
ستعلن Revolution Medicines (ناسداك: RVMD) عن نتائج الربع الثالث من عام 2025 يوم الأربعاء 5 نوفمبر 2025 بعد إغلاق السوق.
قالت الشركة إن بثاً ويبياً لكبار المدراء سيبدأ في الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة / 1:30 مساءً بتوقيت المحيط الهادئ لمناقشة النتائج وتقديم تحديث للشركة. يمكن للمستثمرين الاستماع مباشرة أو الوصول إلى البث المسجل على https://ir.revmed.com/events-and-presentations. سيكون هناك تشغيل مسجّل متاح على موقع الشركة لمدة 14 يوماً على الأقل بعد الحدث المباشر.
Revolution Medicines（纳斯达克: RVMD）将于 2025年11月5日（星期三）收盘后公布2025年第三季度财务业绩。
公司表示，高层管理层的网络广播将于 东部时间下午4:30 / 太平洋时间下午1:30 开始，以讨论业绩并提供公司更新。投资者可以现场收听或访问 https://ir.revmed.com/events-and-presentations 查看归档网络广播。回放将在现场活动结束后至少14天在公司网站上提供。
- None.
- None.
REDWOOD CITY, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the third quarter of 2025 on Wednesday, November 5, 2025, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines’ senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress.
To listen to the live webcast, or access the archived webcast, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcast, a replay will be available on the company’s website for at least 14 days.
About Revolution Medicines, Inc.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are currently in clinical development. The company anticipates that RMC-5127, a RAS(ON) G12V-selective inhibitor, will be its next RAS(ON) inhibitor to enter clinical development. Additional development opportunities in the company’s pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit www.revmed.com and follow us on LinkedIn.
Revolution Medicines Media & Investor Contact:
media@revmed.com
investors@revmed.com
FAQ
When will Revolution Medicines (RVMD) report Q3 2025 financial results?
What time is the Revolution Medicines (RVMD) Q3 2025 webcast on November 5, 2025?
Where can I listen to the Revolution Medicines (RVMD) Q3 2025 earnings webcast?
How long will the Revolution Medicines (RVMD) Q3 2025 earnings replay be available?
Who will present on the Revolution Medicines (RVMD) Q3 2025 earnings call?
